Novel Inhibitors of PARP1/2: A Promising Treatment Approach for BRCA-Negative Cancers, Vascular Disease, and Neurodegeneration
Novel inhibitor compounds that interact with the PARP active site to form effective inhibitors for treatment of cancer and vascular disease
Published: 1st December 2020
Patents
- Patent pending
IP Status
- Patent application submitted
Seeking
- Licensing